Table 1. Participant demographic data for the MC ‘squeeze’ and sham group.
Participant ID # | Gender | Age | Sport/activity | BMI | Onset (duration of symptoms) | Joint line point of treatment | Total treatments |
---|---|---|---|---|---|---|---|
101 | Male | 45 | Football coach | 35.6 BMI | Chronic | Medial | 5 squeeze |
102 | Male | 23 | Football | 32.8 BMI | Chronic | Medial | 4 squeeze |
103 | Female | 53 | General population | 24.0 BMI | Chronic | Lateral | 6 squeeze |
104 | Male | 22 | Soccer | 24.3BMI | Chronic | Medial | 3 squeeze |
105 | Male | 20 | Baseball | 32.5 BMI | Acute | Medial | 5 squeeze |
106 | Male | 21 | Track & field | 23.6 BMI | Acute | Lateral | 6 squeeze |
107 | Male | 14 | Basketball | 18.5 BMI | Acute | Medial | 3 squeeze |
108 | Female | 18 | Dance | 29.9 BMI | Chronic | Lateral | 5 squeeze |
109 | Female | 21 | ROTC | 24.0 BMI | Acute | Medial | 6 squeeze |
110 | Female | 25 | Swim coach | 26.8 BMI | Acute | Medial | 6 squeeze |
111 | Female | 20 | Basketball | 21.30BMI | Chronic | Medial | 6 squeeze |
112 | Male | 16 | Soccer | 18.5 BMI | Acute | Lateral | 4 squeeze |
113a | Male | 33 | Football/track coach | 23.0 BMI | Chronic | Lateral | 6 sham + 4 squeeze |
114a | Male | 19 | Baseball | 25.7 BMI | Chronic | Lateral | 4 sham |
115a | Female | 20 | Soccer | 24.4 BMI | Chronic | Medial | 5 sham |
116a | Female | 19 | Cross country | 20.4 BMI | Acute | Medial | 6 sham + 6 squeeze |
117a | Male | 23 | Football | 31.0 BMI | Acute | Medial | 6 sham + 5 squeeze |
118a | Female | 19 | ROTC | 24.1 BMI | Acute | Lateral | 6 sham |
119a | Female | 18 | Recreational basketball | 21.3 BMI | Chronic | Medial | 6 sham |
120a | Female | 21 | General population | 35.2 BMI | Chronic | Medial | 6 sham + 6 squeeze + 1 MWM** |
121a | Female | 62 | General population | 30.4 BMI | Chronic | Posterior lateral | 6 sham + 4 squeeze |
122a | Male | 23 | General population | 33 BMI | Chronic | Lateral | 5 sham |
123a | Female | 18 | Recreational basketball | 21.3 BMI | Chronic | Medial | 6 sham |
Sham treatment group.
Notes alternate treatment used according to the study protocol in Figure 4.